Divi's Laboratories Ltd. NSE: DIVISLAB | BSE: 532488

Expensive Performer

Download real time

6373.00 -89.50 (-1.38%)

28.62% Gain from 52W Low

136.2K

NSE+BSE Volume

NSE 21 Nov, 2025 3:31 PM (IST)

Divi's Laboratories Ltd. share price target

Divi's Laboratories Ltd. has an average share price target of 6432.50. The consensus estimate represents an upside of 0.93% from the last price of 6373. View 11 reports from 6 analysts offering long-term price targets for Divi's Laboratories Ltd..

Reco - This broker has downgraded this stock from it's previous report.
(eg. - Buy->Hold)

Target - Broker has maintained previous recommendation but reduced share price target.

Reco - This broker has upgraded this stock from it's previous report.
(eg. - Sell->Hold)

Target - Broker has maintained previous recommendation but increased share price target.

Load latest Google or static link led you to an intermediate page.

Click on any table column to sort reports by date, stock name, broker, price, target, upside or recommendation.

Summary	Date	Stock	Author	LTP	Target	Price at reco (Change since reco%)	Upside(%)	Type	Report		Discuss
	22 Nov 2025	Divi's Laboratories	Consensus Share Price Target	6373.00	6785.10	-	6.47	hold	pdf Detailed Estimates
	08 Nov 2022	Divi's Laboratories	Prabhudas Lilladhar Target	6373.00	3300.00	3298.75 (93.19%)	Target met	Hold	pdf post cache		Broker Report DIVI'S LABORATORIES Prabhudas Lilladhar pdf Copy Link Share on Share on Share on Share on Alert
	08 Nov 2022	Divi's Laboratories	ICICI Securities Limited Target	6373.00	3893.00	3414.55 (86.64%)	Target met	Accumulate	pdf post cache		Broker Report Margin dips on fall in revenue ICICI Securities Limited Divi’s Laboratories’ (Divi’s) Q2FY23 performance was sharply below our estimates. Consolidated revenue fell 6.7% YoY to Rs18.5bn (I-Sec: Rs22.9bn), EBITDA margin slipped 770bps YoY to 33.5% (I-Sec: 41.2%) and adjusted PAT declined 18.6% YoY to Rs4.9bn (I-Sec: Rs6.2bn). pdf Copy Link Share on Share on Share on Share on Alert
	08 Nov 2022	Divi's Laboratories	ICICI Direct Reco Target	6373.00	3685.00	3414.55 (86.64%)	Target met	Hold	pdf post cache		Broker Report Divi's Laboratories ICICI Direct pdf Copy Link Share on Share on Share on Share on Alert
	03 Oct 2022	Divi's Laboratories	Ashika Research Target	6373.00	4110.00	3726.85 (71.00%)		Buy	pdf post cache		Broker Report Ashika - Stock Picks Divi's Laboratories Ltd. - October 2022 Ashika Research pdf Copy Link Share on Share on Share on Share on Alert
	25 Aug 2022	Divi's Laboratories	Geojit BNP Paribas Target	6373.00	4006.00	3587.50 (77.64%)		Buy	pdf post cache		Broker Report DIVI' S LAB Geojit BNP Paribas pdf Copy Link Share on Share on Share on Share on Alert
	16 Aug 2022	Divi's Laboratories	ICICI Securities Limited Target	6373.00	4173.00	3726.20 (71.03%)		Accumulate	pdf post cache		Broker Report Recovery in API; margins hit ICICI Securities Limited Divi’s Laboratories’ (Divi’s) Q1FY23 performance was a mixed bag with revenue ahead of our estimates while margin was lower. pdf Copy Link Share on Share on Share on Share on Alert
	15 Aug 2022	Divi's Laboratories	Prabhudas Lilladhar Target	6373.00	4140.00	3732.00 (70.77%)		Accumulate	pdf post cache		Broker Report DIVI'S LABORATORIES Prabhudas Lilladhar pdf Copy Link Share on Share on Share on Share on Alert
	13 Aug 2022	Divi's Laboratories	BOB Capital Markets Ltd.	6373.00	4250.00	3726.20 (71.03%)		Hold	pdf post cache		Broker Report Divi's Labs (HOLD): No respite in sight for margins BOB Capital Markets Ltd. Q1 revenue broadly in line with consensus at Rs 22.5bn (+15% YoY/-10% QoQ), but EBITDA 10% below pdf Copy Link Share on Share on Share on Share on Alert
	12 Aug 2022	Divi's Laboratories	ICICI Direct Target	6373.00	4315.00	3726.20 (71.03%)		Buy	pdf post cache		Broker Report Divi's Laboratories ICICI Direct pdf Copy Link Share on Share on Share on Share on Alert
	26 May 2022	Divi's Laboratories	SMC online	6373.00		3514.70 (81.32%)		Results Update	pdf post cache		Broker Report Divis Laboratories Limited SMC online pdf Copy Link Share on Share on Share on Share on Alert
more loading

* Please note that subscribers can download a maximum of 300 reports a month and 70 reports everyday.

Advisor Screeners